Transient neurologic symptoms following spinal lignocaine and bupivacaine for caesarean delivery at Mulago Hospital: A randomised trial (“the Li-Bu Trial”)

dc.contributor.author Lubikire, Aggrey
dc.date.accessioned 2014-11-01T09:57:56Z
dc.date.available 2014-11-01T09:57:56Z
dc.date.issued 2014-06
dc.description A Thesis submitted to the Graduate School in partial fulfillment of the requirements for the award of the Degree of Master of Medicine in Anaesthesiology and Critical Care of Makerere University en_US
dc.description.abstract Introduction: Transient neurological symptoms (TNS) are defined as symmetrical bilateral pain/ dysthesia in the back or buttocks or pain radiating to the lower extremities 24 hours after recovery from spinal anesthesia . In Mulago Hospital (National Referral and teaching hospital), Spinal Lignocaine and Spinal Bupivacaine are the drugs of choice for facilitating caesarean delivery by neuraxial blockade. However , both have been implicated in the causation of Transient Neurological Symptoms from studies conducted in Europe and America with spinal lignocaine being the worse drug. Objective: To determine the incidence of TNS following use of spinal Lignocaine and spinal Bupivacaine and any other factors that may contribute to the development of TNS during neuraxial blockade in parturients for caesarean section at Mulago NRH. Design:The study was blind random controlled trial, to determine the incidence of TNS in mothers receiving either spinal Lignocaine or Bupivacaine for caesarean section at Mulago teaching hospital.. This study were ducted on the 5th floor in the Obstetric and Gynaenacology theatres. Potential cases for the study was recruited from either emergency or elective caesarean patients. Methodology: Following ethical approval, we conducted as a randomized double blinded controlled trial..Consented patients were randomized to two arms;Lignocaine and Bupivacaine arms respectively. Mothers were followed from 24-72 hours post spinal for and responded to researcher administered questions to assess presence of TNS .The Trial was registered with the Pan African Clinical Trials:PACTR201306000510382. Results: 200 cases met the inclusion criteria, then doubly blinded and randomized to two arms. There was TNS with either arm; 11 (5.5%) cases in the Bupivacaine arm with incidence rate of 0.11, and 8 cases (4%),with incidence of 0.08, had TNS in the Lignocaine arm. The incidence rate ratio (IRR) is 1.375(95%CI), p-value 0.531. Statistically there was no difference in the incidence of TNS in either arm. Conclusions: No statistical difference noted between spinal Bupivacaine and Lignocaine in the causation of TNS in Mulago NRH among the parturients for C-section. Key Words: Transient Neurologic symptoms, Neural axial block, spinal Lignocaine and Bupivacaine, Ceasarean Section. en_US
dc.description.sponsorship Global Partners in Anesthesia and Surgery (GPAS), the Association of Anaesthetists of Great Britain and Ireland (AAGBI), Difficult Airway Association (DAS), and Ministry of Health (Uganda) en_US
dc.identifier.citation Lubikire, A. (2014). Transient neurologic symptoms following spinal lignocaine and bupivacaine for caesarean delivery at Mulago Hospital: A randomised trial (“the Li-Bu Trial”) (Unpublished master's thesis). Makerere University, Kampala, Uganda en_US
dc.identifier.uri http://hdl.handle.net/10570/4067
dc.language.iso en en_US
dc.publisher Makerere University en_US
dc.subject Caesarean delivery en_US
dc.subject Spinal lignocaine en_US
dc.subject Bupivacaine en_US
dc.subject Transient neurology en_US
dc.subject Symptoms en_US
dc.subject Randomised trial en_US
dc.title Transient neurologic symptoms following spinal lignocaine and bupivacaine for caesarean delivery at Mulago Hospital: A randomised trial (“the Li-Bu Trial”) en_US
dc.type Thesis en_US
Files